TRACY SOUTHERN: Open Payments
NPI 1740726660 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,466 in 83 payments from 24 companies in 2025. Trend: 2023 $1,410 · 2024 $1,598 · 2025 $1,466
Food & beverage: $1,466
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $333 |
| AstraZeneca Pharmaceuticals LP | 9 | $212 |
| Lilly USA, LLC | 6 | $111 |
| Amgen Inc. | 5 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| PFIZER INC. | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
Products named: VRAYLAR, BREZTRI, MOUNJARO, JARDIANCE, CAPLYTA, QULIPTA, UBRELVY, FARXIGA.
Industry payments across MO — which companies pay providers there.
